Replies to post #12648 on Titan Pharmaceuticals Inc (TTNP)

[rikshot]

Quotes From Zach's report in your last post:


These assumptions add approximately $1.00 to our previous target price to yield a $6.00 valuation for Titan.
Our additions to the model result in a target increase to $6.00 per share recognizing the contribution of Probuphine in Europe.